How much cash does Biodesix, Inc. generate?

Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.

What is Biodesix, Inc.'s free cash flow?

After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.

Where does Biodesix, Inc.'s cash flow data come from?

Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Biodesix, Inc. BDSX Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	-$35.27M+17.9%	-$42.93M+17.7%	-$52.15M+20.3%	-$65.45M-51.6%
Depreciation and amortization	$5.67M-1.8%	$5.77M+73.5%	$3.33M-7.5%	$3.6M+13.2%
Stock-based compensation	$4.14M-37.6%	$6.64M+23.5%	$5.37M-9.9%	$5.96M+20.6%
Provision for credit losses	$180K-79.7%	$887K+78.5%	$497K—	——
Change in accounts receivable	——	——	$4.72M—	——
Change in accounts payable	$1.86M—	——	$513K—	——
Change in other assets	$130K+291%	-$68K—	——	$3.65M—
Change in deferred revenue	——	——	-$755K+37.8%	-$1.21M+31.5%
Amortization of intangible assets	$107K-55.0%	$238K—	——	——
Change in operating lease liabilities	-$789K-210%	$715K—	——	-$937K—
Change in other current assets	$258K—	——	——	——
Net cash from operating activities	-$24.05M+50.6%	-$48.65M-104%	-$23.81M+47.1%	-$44.97M-53.4%
Capital expenditures	$259K-92.0%	$3.23M-85.9%	$22.92M+595%	$3.3M+47.2%
Net cash from investing activities	-$403K+88.3%	-$3.44M+85.1%	-$23.06M-553%	-$3.53M-38.8%
Repayments of debt	$21K-58.8%	$51K+4.1%	$49K-99.8%	$28.94M-36.3%
Proceeds from issuance of common stock	——	——	$28.13M-52.8%	$59.54M+264%
Other financing activities	-$817K-83.6%	-$445K-105%	$8.58M-20.7%	$10.82M—
Payment of debt issuance costs	$30K-31.8%	$44K-94.7%	$833K—	——
Net cash from financing activities	$16.42M-68.6%	$52.23M+79.3%	$29.13M-52.4%	$61.15M—
Net increase (decrease) in cash	——	-$39K—	——	$10.38M+134%
Interest paid	$6.4M-8.9%	$7.02M+75.9%	$3.99M+296%	$1.01M-39.8%
Accrued Interest Amortization Of Debt Issuance Costs And Other	$1.3M-47.0%	$2.46M-51.8%	$5.11M+1.5%	$5.04M+86.1%
Operating lease liabilities	-$789K-210%	$715K—	——	-$937K—
Increase (Decrease) in Other Current Assets	$258K—	——	——	——
Inventory write-downs	——	$22K-86.7%	$166K-81.7%	$906K—
Operating Lease Right Of Use Asset Reduction Accretion Amortization Expense	——	——	——	——
Provision for Loan, Lease, and Other Losses	$180K-79.7%	$887K+78.5%	$497K—	——
Payments For Proceeds From Patent Costs And Intangible Asset Acquisition Net	$144K-31.4%	$210K+46.9%	$143K-39.4%	$236K-22.9%
Payment Of Equity Financing Costs	——	$3.69M—	——	$3.07M—
Payments Of Debt Issuance Costs	$30K-31.8%	$44K-94.7%	$833K—	——
Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan	——	$625K—	——	——
Other, net	-$817K-83.6%	-$445K-137%	-$188K-470%	-$33K—
Fair Value Adjustment Of Warrants	——	——	——	-$84K—
Increase Decrease In Contract With Customer Liability	——	——	-$755K+37.8%	-$1.21M+31.5%
Increase Decrease In Operating Lease Liability	-$789K-210%	$715K—	——	-$937K—
Leased assets obtained in exchange for finance lease liabilities	$1.45M—	——	——	——
Leased assets obtained in exchange for operating lease liabilities	——	——	$867K-78.0%	$3.94M—
Debt Issuance Costs Included In Accounts Payable And Other Accrued Liabilities	——	——	$18K—	——
Equity Financing Costs Included In Accounts Payable And Other Accrued Liabilities	$7K—	——	——	——
Issuance Of Sixth Amendment Warrants	——	——	——	——
Free cash flow	-$24.22M+53.3%	-$51.88M-13.3%	-$45.79M+5.1%	-$48.27M-54.4%
Free cash flow	-$24.22M+53.3%	-$51.88M-13.3%	-$45.79M+5.1%	-$48.27M-54.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Biodesix, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Biodesix, Inc. generate?: Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
What is Biodesix, Inc.'s free cash flow?: After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
Where does Biodesix, Inc.'s cash flow data come from?: Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.